<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HAB7A06D376F64575BFA5C2554BAB8E9F" public-private="public" key="H" bill-type="olc"><form><distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 872</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170206">February 6, 2017</action-date><action-desc><sponsor name-id="L000582">Mr. Ted Lieu of California</sponsor> (for himself, <cosponsor name-id="C001080">Ms. Judy Chu of California</cosponsor>, <cosponsor name-id="C000984">Mr. Cummings</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="M001160">Ms. Moore</cosponsor>, and <cosponsor name-id="S000480">Ms. Slaughter</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to enhance medical device communications and ensure device cleanliness.</official-title></form><legis-body id="HBFAD0D5B2E4C4CA388F0D8A12BD5003E" style="OLC"> 
<section id="H6A7EF19EA42045E392BD3AD3DAB39CB4" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Disclosure; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2017</short-title></quote> or the <quote>DEVICE Act of 2017</quote>.</text></section> <section id="HDB1DDA0D8C4F4004AF3F39BDFC04078B"><enum>2.</enum><header>Reporting requirement for design and reprocessing instruction changes</header> <subsection id="H9AEFD574D6E1476DB8E8FBF836A8D546"><enum>(a)</enum><header>Adulteration</header><text display-inline="yes-display-inline">Section 501 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/351">21 U.S.C. 351</external-xref>) is amended by inserting after paragraph (j) the following:</text> 
<quoted-block display-inline="no-display-inline" id="HBD2496411DFC4946BA4B1229E914FE94" style="OLC"> 
<subsection id="H3BE6512D91A14DCAAB65B62BACE79584"><enum>(k)</enum><text display-inline="yes-display-inline">If it is a device with respect to which the manufacturer is in violation of the reporting requirement in section 510(q) (relating to design and reprocessing changes).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="HA48F9D1A298646F3AE4A757684815987"><enum>(b)</enum><header>Requirement</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>) is amended by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="H09F50154692A4548B4B61A0D62E324ED" style="OLC"> 
<subsection id="H7FD209F736F74BEF9F94FFD9DB310490"><enum>(q)</enum><header>Reporting requirement for device design changes</header><text display-inline="yes-display-inline">Before making a change to the design of a device, or the reprocessing instructions of a device, that is marketed in interstate commerce, the manufacturer of the device shall give written notice of the change to the Food and Drug Administration.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section> <section id="H8EC09747E6174592B4E874B7EA8B7A6A"><enum>3.</enum><header>Reporting requirement for certain communications to foreign health care providers</header> <subsection id="H8EF3BA40E8234E7E85303765E56C6530"><enum>(a)</enum><header>Adulteration</header><text display-inline="yes-display-inline">Section 501 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/351">21 U.S.C. 351</external-xref>), as amended by section 2 of this Act, is further amended by inserting after paragraph (k) the following:</text> 
<quoted-block display-inline="no-display-inline" id="HCB03D874BD264804915799B8F415E826" style="OLC"> 
<subsection id="H6E8356C4AFBB484EB3F67198228E16BE"><enum>(l)</enum><text display-inline="yes-display-inline">If it is a device with respect to which the manufacturer is in violation of the reporting requirement in section 510(r) (relating to communications to foreign health care providers).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="H8D35FF44095F476CAAD5520690CBB74B"><enum>(b)</enum><header>Requirement</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>), as amended by section 2 of this Act, is further amended by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="H74E95D7C1C74418EAD7077D7C242C7F7" style="OLC"> 
<subsection id="H65330DEEF0AC42BCAB44EA7589A63FCD"><enum>(r)</enum><header>Reporting requirement for certain communications to foreign health care providers</header> 
<paragraph id="H22E4CCBB89F245BFA8B727D9CA1B7312"><enum>(1)</enum><header>Requirement</header><text display-inline="yes-display-inline">The manufacturer of a device that is marketed in interstate commerce shall give written notice to the Food and Drug Administration of any communication described in paragraph (2) not more than 5 calendar days after making such communication.</text></paragraph> <paragraph id="H934F14B15B6B4A9F9E3797760A1BDC9C"><enum>(2)</enum><header>Communication described</header><text>A communication is described in this paragraph if the communication—</text> 
<subparagraph id="H8F361850530644CEA311E2737DAB0F19"><enum>(A)</enum><text>is made by the manufacturer of the device or an affiliate of the manufacturer;</text></subparagraph> <subparagraph id="HF02984CAB2314A02AD9DA3E5C3DAC408"><enum>(B)</enum><text>relates to a change to the design of the device, a change to the recommended reprocessing protocols, if any, for the device, or a safety concern about the device; and</text></subparagraph> 
<subparagraph id="H4571F353A7A440E68F6E8A2E54B0D366"><enum>(C)</enum><text>is widely disseminated (including on a voluntary basis) to health care providers in a foreign country.</text></subparagraph></paragraph> <paragraph id="HCCB159405AB4415DA2D6E0D8A8BFD53F"><enum>(3)</enum><header>Affiliate</header><text display-inline="yes-display-inline">In this subsection, the term <term>affiliate</term> means a business entity that has a relationship with a second business entity if, directly or indirectly—</text> 
<subparagraph id="H4D19EC2144864CBD8A029FFFDFC8ECA2"><enum>(A)</enum><text>one business entity controls, or has the power to control, the other business entity; or</text></subparagraph> <subparagraph id="H9EA8DF52A88F4ADEBFB1EB7C8FEF3E9C"><enum>(B)</enum><text>a third party controls, or has the power to control, both of the business entities.</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section> 
<section id="HB2C32E532B564414AF36E102D2C95ABA"><enum>4.</enum><header>Rapid assessment tests intended to ensure proper reprocessing</header> 
<subsection id="H3448C50E7CD1418A8199BD518DF3F569"><enum>(a)</enum><header>Inclusion in device definition</header><text display-inline="yes-display-inline">Section 201 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321</external-xref>) is amended—</text> <paragraph id="H3D9A0B9D79AA479E9BF8085CE9AB4204"><enum>(1)</enum><text>in paragraph (h)—</text> 
<subparagraph id="H56096A9F0A5E41FCB80D71F87854CCA8"><enum>(A)</enum><text>in subparagraph (2), by striking <quote>or</quote> at the end;</text></subparagraph> <subparagraph id="HE37ED3EF364D4CEAABE38EC43E883FB7"><enum>(B)</enum><text>in subparagraph (3), by striking <quote>and</quote> at the end and inserting <quote>or</quote>; and</text></subparagraph> 
<subparagraph id="H4CA59E4D85CC46FE84E374E383E2B3C9"><enum>(C)</enum><text>by inserting after subparagraph (3) the following:</text> <quoted-block display-inline="no-display-inline" id="HA8ADA71BBB6B408C99065D9B740F034C" style="OLC"> <paragraph id="H3A02CA7487EC4174A26A6DA57394F5C8"><enum>(4)</enum><text display-inline="yes-display-inline">a rapid assessment test intended to ensure the proper reprocessing of a reusable device (as defined in paragraph (ss)), and</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph> 
<paragraph id="HC140FCB8AD954A909453D9828FC2D4B2"><enum>(2)</enum><text>by adding at the end the following:</text> <quoted-block display-inline="no-display-inline" id="HFA13018E4F034B7ABC8D8EC6295A5616" style="OLC"> <subsection id="H527F53047A7C4FD39003FF5C8AC006E0"><enum>(ss)</enum><text display-inline="yes-display-inline">The term <term>reusable device</term> means a device that—</text> 
<paragraph id="HF36E511FE8824161ABB9EB7FD9C8B6E5"><enum>(1)</enum><text>is intended to be used more than one time; and</text></paragraph> <paragraph id="H868E76102D3046F0A87A36DE874F2C39"><enum>(2)</enum><text display-inline="yes-display-inline">must be sanitized (whether through cleaning, disinfection, or sterilization) to ensure that the device is safe and effective for such intended use.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection> 
<subsection id="HB855EF906ABF4C3DBC8A7611BD74CC56"><enum>(b)</enum><header>Instructions for use and validation data</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>), as amended by sections 2 and 3 of this Act, is further amended by adding at the end the following:</text> <quoted-block display-inline="no-display-inline" id="H5A04CA90C7B1467C9D9CD1EF45AEBE62" style="OLC"> <subsection id="HFA9AB4E360564B2E8468EEA643CE0337"><enum>(s)</enum><header>Instructions for use and validation data</header> <paragraph id="HCF64DA0A37AF48409604800AC50AD4B1"><enum>(1)</enum><header>Initial list</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this subsection, the Secretary shall by regulation develop and publish a list of types of rapid assessment tests described in section 201(h)(4) for which reports under subsection (k) must include—</text> 
<subparagraph id="H7FE06D1D811C403397A110A181C5BA06"><enum>(A)</enum><text>instructions for use that have been validated in a manner specified by the Secretary; and</text></subparagraph> <subparagraph id="H5A4EB9CDDD0644B8B989FF9E6A872567"><enum>(B)</enum><text>validation data, of the types specified by the Secretary.</text></subparagraph></paragraph> 
<paragraph id="H64000B7C53A3480FB0FEE6BF6E705FB0"><enum>(2)</enum><header>Updates</header><text display-inline="yes-display-inline">The Secretary shall by regulation periodically update the list required by paragraph (1).</text></paragraph> <paragraph id="H927C744348DA4888AB35F906627827F4"><enum>(3)</enum><header>Enforcement</header><text>Beginning on the date of publication of the initial list under paragraph (1), the Secretary shall not accept any notification under subsection (k) for clearance of a type of rapid assessment test that is included on such list unless such notification includes instructions for use and validation data in accordance with paragraph (1).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section> 
</legis-body></bill>

